Diamyd appoints Peter Zerhouni as President
The Board of Diamyd Medical has appointed Peter Zerhouni, Acting President of Diamyd Medical AB, as President of the Company.Peter Zerhouni has been involved in all aspects of the Company since 2006 and he is since April 2011 Acting President and CEO of the Company. He assumes his position as President and CEO of Diamyd Medical AB on July 4, 2011. Peter Zerhouni has during the years played a key role in driving the Company’s business and clinical trials forward. He has a combined financial and biotechnology background with degrees in Biology and Economics & Business Administration from
